Expansion of myeloid suppressor cells in SHIP-deficient mice represses allogeneic T cell responses

Journal of Immunology

Volumn 173, Issue 12, 2004, Pages 7324-7330

  Ghansah, Tomar ^a,b   Paraiso, Kim H T ^a,b   Highfill, Steven ^a,b   Desponts, Caroline ^a,b   May, Sarah ^a,b   McIntosh, Joseph K ^a,b   Wang, Jia Wang ^a,b   Ninos, John ^a,b   Brayer, Jason ^a,b   Cheng, Fengdong ^a,b   Sotomayor, Eduardo ^a,b   Kerr, William G ^a,b  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOGENEIC RESTRICTION; ANIMAL CELL; ARTICLE; BONE MARROW CELL; BONE MARROW TRANSPLANTATION; CELL STIMULATION; CONTROLLED STUDY; DENDRITIC CELL; EPITOPE MAPPING; GRAFT REJECTION; GRAFT VERSUS HOST REACTION; LYMPH NODE CELL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; T LYMPHOCYTE ACTIVATION;

EID: 10344239895     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.173.12.7324     Document Type: Article

References (35)

1. Levy, R. B., M. Baker, and E. R. Podack. 1995. Perorin-deficient T cells can induce acute graft-versus-host disease after transplantation of MHC disparate allogeneic bone marrow. Ann. NY Acad. Sci. 770:366.
2. Baker, M. B., N. H. Altman, E. R. Podack, and R. B. Levy. 1996. The role of cell mediated cytotoxicity in acute GvHD after MHC-matched allogeneic bone marrow transplantation in mice. J. Exp. Med. 183:2645.
3. Steinman, R. M. 2001. Dendritic cells and the control of immunity: enhancing the efficiency of antigen presentation. Mt. Sinai J. Med. 68:106.
4. Banchereau, J., and R. M. Steinman. 1998. Dendritic cells and the control of immunity. Nature 392:245.
5. Chambers, C. A., M. S. Kuhns, J. G. Egen, and J. P. Allison. 2001. CTLA-4 mediated inhibition in regulation of T cells responses: mechanisms and manipulation in tumor immunotherapy. Annu. Rev. Immunol. 19:565.
6. Helgason, C. D., J. E. Damen, P. Rosten, R. Grewal, P. Sorensen, S. M. Chappel, A. Borowski, F. Jirik, G. Krystal, and R. K. Humphries. 1998. Targeted disruption of SHIP leads to hemopoietic perturbations, lung pathology, and a shortened life span. Genes Dev. 12:1610.
7. Liu, Q., T. Sasaki, I. Kozieradzki, A. Wakeham, A. Itie, D. J. Dumont, and J. M. Penninger. 1999. SHIP is a negative regulator of growth factor receptor-mediated PKB/Akt activation and myeloid cell survival. Genes Dev. 13:786.
8. Takeshita, S., N. Namba, J. J. Zhao, Y. Jiang, H. K. Genant, M. J. Silva, M. D. Brodt, C. D. Helgason, J. Kalesnikoff, M. J. Rauh, et al. 2002. SHIP-deficient mice are severely osteoporotic due to increased numbers of hyper-resorptive osteoclasts. Nat. Med. 8:943.
9. Wang, J. W., J. M. Howson, T. Ghansah, C. Desponts, J. M. Ninos, S. L. May, K. H. Nguyen, N. Toyama-Sorimachi, and W. G. Kerr. 2002. Influence of SHIP on the NK repertoire and allogeneic bone marrow transplantation. Science 295:2094.
10. Alleva, D. G., T. M. Walker, and K. D. Elgert. 1995. Induction of macrophage suppressor activity by fibrosarcoma-derived transforming growth factor-B1: contrasting effects on resting and activated macrophages. J. Leukocyte. Biol. 57:919.
11. Mazzoni, A., V. Bronte, A. Visintin, J. H. Spitzer, E. Apolloni, P. Serafini, P. Zanovello, and D. M. Segal. 2002. Myeloid suppressor lines inhibit T cell responses by an NO-dependent mechanism. J. Immunol 168:689.
12. Angulo, I., R. Rodriguez, B. Garcia, M. Medina, J. Navaro, and J. L. Subiza. 1995. Involvement of nitric oxide in bone marrow-derived natural suppressor activity. J. Immunol. 155:15.
13. + myeloid cells. J. Immunol. 166:5398.
14. Shlomchik, W. D., M. S. Couzens, C. B. Tang, J. McNiff, M. E. Robert, J. Liu, M. J. Shlomchik, and S. G. Emerson. 1999. Prevention of graft versus host disease by inactivation of host antigen-presenting cells. Science 285:412.
15. Korngold, B., and J. Sprent. 1978. Lethal graft-versus-host disease after bone marrow transplantation across minor histocompatibility barriers in mice. Prevention by removing mature T cells from marrow. J. Exp. Med. 148:1687.
16. Onoe, K., G. Fernandes, and R. A. Good. 1980. Humoral and cell-mediated immune responses in fully allogeneic bone marrow chimera in mice. J. Exp. Med. 151:115.
17. Almaraz, R., W. Ballinger, D. H. Sachs, and S. A. Rosenberg. 1983. The effect of peripheral lymphoid cells on the incidence of lethal graft versus host disease following allogeneic mouse bone marrow transplantation. J. Surg. Res. 34:133.
18. Steinman, R. M., B. Gutchinov, M. D. Witmer, and M. C. Nussenzweig. 1983. Dendritic cells are the principal stimulators of the primary mixed leukocyte reaction in mice. J. Exp. Med. 157:613.
19. Kurts, C., W. R. Heath, F. R. Carbone, J. Allison, J. F. Miller, and H. Kosaka. 1996. Constitutive class I-restricted exogenous presentation of self antigens in vivo. J. Exp. Med. 184:923.
20. Robertson, J. M., P. E. Jensen, and B. Evavold. 2000. DO11.10 and OT-II T cells recognize a C-terminal ovalbumin 323-339 epitope. J. Immunol. 164:4706.
21. Camilla, C., J. P. Defoort, M. Delaage, R. Auer, J. Quintana, T. Lary, R. Hamelik, S. Prato, B. Casano, M. Martin, et al. 1998. A new flow cytometry-based multi-assay system. I: Application to cytokine immunoassays. Cytometry 8(Suppl.):312.
22. Liu, Q., A. J. Oliveira-Dos-Santos, S. Mariathasan, D. Bouchard, J. Jones, R. Sarao, I. Kozieradzki, P. S. Ohashi, J. M. Penninger, and D. J. Dumont. 1998. The inositol polyphosphate 5-phosphatase SHIP is a crucial negative regulator of B cell antigen receptor signaling. J. Exp. Med. 188:1333.
23. -/- mice. J. Exp. Med. 191:781.
24. Steinman, R. M., and M. D. Witmer. 1978. Lymphoid dendritic cells are potent stimulators of the primary mixed leukocyte reaction in mice. Proc. Natl. Acad. Sci. USA 75:5132.
25. + T cells by semiprofessional antigen-presenting cells in vivo. J. Exp. Med. 176:1291.
26. Teshima, T., R. Ordemann, P. Reddy, S. Gagin, C. Liu, K. R. Cooke, and J. L. Ferrara. 2002. Acute graft-versus-host disease does not require alloantigen expression on host epithelium. Nat. Med. 8:575.
27. Bronte, V., P. Serafini, A. Mazzoni, D. M. Segal, and P. Zanovello. 2003. L-arginine metabolism in myeloid cells controls T-lymphocyte functions. Trends Immunol. 24:302.
28. Souza, J. P., M. Boeckh, T. A. Gooley, M. E. Flowers, and S. W. Crawford. 1999. High rates of Pneumocystis carinii pneumonia in allogeneic blood and marrow transplant recipients receiving dapsone prophylaxis. Clin. Infect. Dis. 29:1467.
29. + cells. J. Immunol. 161:5313.
30. + T cell responses by dysregulating antigen-presenting cell maturation. J. Immunol. 162:5728.
31. Huang, Z. Y., S. Hunter, M. K. Kim, Z. K. Indik, and A. D. Schreiber. 2003. The effect of phosphatases SHP-1 and SHIP-1 on signaling by the ITIM- and ITAM-containing Fcγy receptors Fcγ RIIB and Fcγ RIIA. J. Leukocyte. Biol. 73:823.
32. MacMicking, J., Q. W. Xie, and C. Nathan. 1997. Nitric oxide and macrophage function. Anna. Rev. Immunol. 15:323.
33. Otsuji, M., Y. Kimura, T. Aoe, Y. Okamoto, and T. Saito. 1996. Oxidative stress by tumor-derived macrophages suppresses the expression of CD3 chain of T-cell receptor complex and antigen-specific T-cell responses. Proc. Natl. Acad. Sci. USA 93:13119.
34. Watson, G. A., and D. M. Lopez. 1995. Aberrant antigen presentation by macrophages from tumor-bearing mice is involved in the down-regulation of their T cell responses. J. Immunol. 155:3124.
35. Storb, R. 2003. Allogeneic hematopoietic stem cell transplantation: yesterday, today, and tomorrow. Exp. Hematol. 31:1.